CLINICAL_TRIALS
trial_result
· 2011-10-27
Clinical Trial Update: Pentoxifylline in Duchenne Muscular Dystrophy [Phase 1, Phase 2]
Summary
A Phase 1/2 trial of pentoxifylline in Duchenne muscular dystrophy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cooperative International Neuromuscular Research Group | Conditions: Muscular Dystrophy, Duchenne | Phase 1, Phase 2 | Status: COMPLETED